Kanawha Capital Management LLC Sells 200 Shares of The Clorox Company $CLX

Kanawha Capital Management LLC cut its stake in shares of The Clorox Company (NYSE:CLX) by 5.0% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,800 shares of the company’s stock after selling 200 shares during the period. Kanawha Capital Management LLC’s holdings in Clorox were worth $456,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Vanguard Group Inc. increased its position in shares of Clorox by 0.4% during the first quarter. Vanguard Group Inc. now owns 15,573,076 shares of the company’s stock valued at $2,293,135,000 after buying an additional 65,924 shares during the period. Northern Trust Corp increased its position in shares of Clorox by 2.3% during the first quarter. Northern Trust Corp now owns 1,528,920 shares of the company’s stock valued at $225,133,000 after buying an additional 34,655 shares during the period. Invesco Ltd. increased its position in shares of Clorox by 7.4% during the first quarter. Invesco Ltd. now owns 1,361,710 shares of the company’s stock valued at $200,512,000 after buying an additional 94,371 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in shares of Clorox by 3.7% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,157,257 shares of the company’s stock valued at $170,406,000 after buying an additional 41,485 shares during the period. Finally, Hsbc Holdings PLC increased its position in shares of Clorox by 118.8% during the first quarter. Hsbc Holdings PLC now owns 1,085,661 shares of the company’s stock valued at $159,699,000 after buying an additional 589,544 shares during the period. 78.53% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

CLX has been the topic of several analyst reports. UBS Group decreased their price target on Clorox from $134.00 to $128.00 and set a “neutral” rating on the stock in a research report on Wednesday, October 8th. Jefferies Financial Group decreased their price objective on shares of Clorox from $167.00 to $145.00 and set a “buy” rating on the stock in a research report on Thursday, June 26th. The Goldman Sachs Group decreased their price objective on shares of Clorox from $115.00 to $110.00 and set a “sell” rating on the stock in a research report on Wednesday, October 1st. Barclays decreased their price objective on shares of Clorox from $118.00 to $112.00 and set an “underweight” rating on the stock in a research report on Tuesday, September 30th. Finally, Bank of America decreased their price objective on shares of Clorox from $135.00 to $125.00 and set a “neutral” rating on the stock in a research report on Wednesday, October 8th. One equities research analyst has rated the stock with a Buy rating, twelve have given a Hold rating and four have assigned a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Reduce” and an average target price of $130.20.

Insider Buying and Selling

In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of the stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the transaction, the chief operating officer directly owned 54,221 shares in the company, valued at $6,711,475.38. This trade represents a 21.72% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.63% of the stock is owned by insiders.

Clorox Stock Up 1.8%

Shares of NYSE CLX opened at $119.73 on Friday. The Clorox Company has a one year low of $116.53 and a one year high of $171.37. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57. The firm’s 50 day simple moving average is $121.61 and its two-hundred day simple moving average is $127.73. The stock has a market capitalization of $14.58 billion, a P/E ratio of 18.36, a PEG ratio of 0.99 and a beta of 0.52.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Thursday, July 31st. The company reported $2.87 EPS for the quarter, beating analysts’ consensus estimates of $2.24 by $0.63. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The business had revenue of $1.99 billion for the quarter, compared to analysts’ expectations of $1.94 billion. During the same period last year, the business earned $1.82 earnings per share. The business’s quarterly revenue was up 4.5% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. As a group, analysts expect that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, November 6th. Shareholders of record on Wednesday, October 22nd will be given a dividend of $1.24 per share. This represents a $4.96 dividend on an annualized basis and a yield of 4.1%. The ex-dividend date is Wednesday, October 22nd. Clorox’s dividend payout ratio (DPR) is presently 76.07%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.